Trial Profile
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Vasomotor rhinitis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 28 Aug 2012 New trial record